SCHEDULE: Barclays PLC Discloses 8.42% Stake in Vendome Acquisition Corp-A

Barclays PLC has reported a beneficial ownership of 8.42% in Vendome Acquisition Corp-A's common stock as of September 30, 2025.

Summary

• Barclays PLC, a UK-based parent holding company, has filed a Schedule 13G disclosing its beneficial ownership in Vendome Acquisition Corp-A.
• As of September 30, 2025, Barclays PLC beneficially owns 1,685,800 shares of Vendome Acquisition Corp-A's common stock.
• This ownership represents 8.42% of the class of securities.
• Barclays PLC holds sole voting power and sole dispositive power over all 1,685,800 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: This is a factual disclosure of beneficial ownership, which is neutral in sentiment. It does not contain positive or negative operational or financial news.

Positives

• NA

Negatives

• NA

Risks

• NA

Future Outlook

NA

Management Comments

• Barclays PLC certifies that, to the best of its knowledge and belief, the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.

Industry Context

This filing indicates a significant institutional investment by a major global financial institution in a SPAC (Special Purpose Acquisition Company) or a company that was formerly a SPAC, which is a common practice for large banks and asset managers.

Stakeholder Impact

• Shareholders: Disclosure of a significant institutional holder provides transparency regarding the company's ownership structure and may influence investor perception.

Key Dates

Keywords

Barclays PLC, Vendome Acquisition Corp-A, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Ownership, SEC Filing